Yahoo Web Search

Search results

  1. 17 hours ago · NEW YORK, July 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic ...

  2. 6 hours ago · Mr. Tardio most recently served as Chief Operating Officer of Ovid Therapeutics Inc. since June 2021, after joining the company as Chief Commercial Officer in November 2019. While there, he led ...

  3. 17 hours ago · "Jason's extensive experience, most notably related to the launch and commercialization of successful multiple sclerosis (MS) drugs for both Novartis and Biogen, as well as his history of significant out-licensing transactions provide Immunic with an invaluable and proven skill as we draw closer to completion of vidofludimus calcium's phase 3 ENSURE program," stated Daniel Vitt, Ph.D., Chief ...